Skip to main content
CivicGate

HR 10770
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

340B Rebate Model Delay Act

To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program.

Introduced Oct 9, 2026

Latest action (Oct 9, 2026) Referred to the House Committee on Energy and Commerce.

Referred to
Energy and Commerce Committee
Policy area
Health
Issues
Healthcare

Summary
  • Sets the short title "340B Rebate Model Delay Act."
  • From January 1, 2027, through December 31, 2028, bars HHS from entering 340B agreements with drug manufacturers that require covered entities to pay more than the applicable ceiling price at the point of purchase for covered outpatient drugs (with an exception for the entities described in paragraph (4)(E)).
  • For the same period, bars HHS from implementing the 340B Rebate Model Pilot Program described in the August 3, 2026 Federal Register notice (91 Fed. Reg. 48883), or any substantially similar program.
  • Applies these limits for a two-year window, after which the restrictions end on December 31, 2028.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)
17 cosponsors

Money behind the sponsor

Top reported contributors to Robert P. Bresnahan’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.

  • Employer not reported $255,976
  • INVESTMENTS LIMITED $21,106
  • STARKEY HEARING TECHNOLOGIES $13,200
  • TFP LIMITED $11,022
  • ENERGY TRANSFER PARTNERS $9,900

Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Robert P. Bresnahan → · Outside spending →

Actions (2)
  1. Oct 9, 2026 Referred to the House Committee on Energy and Commerce. · house
  2. Oct 9, 2026 Introduced in House

Full text

IN THE HOUSE OF REPRESENTATIVES

October 9, 2026

Mr. Bresnahan (for himself, Mrs. Dingell, Mr. Mann, and Ms. Lois Frankel of Florida) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To amend title III of the Public Health Service Act to temporarily limit the use of rebates under the 340B Program.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “340B Rebate Model Delay Act”.

SEC. 2. LIMITING USE OF REBATES UNDER THE 340B PROGRAM.

(a) In General.—Section 340B(a) of the Public Health Service Act (42 U.S.C. 256b(a)) is amended by adding at the end the following new paragraph:

“(11) Temporary limit on use of rebates.—For the period beginning on January 1, 2027, the date of enactment of this paragraph, and ending on December 31, 2028, the Secretary may not enter into an agreement with a manufacturer of covered outpatient drugs under paragraph (1) under which the amount required to be paid to the manufacturer for covered outpatient drugs by a covered entity (other than a covered entity described in paragraph (4)(E)) exceeds, at the point of purchase of such drug, the applicable ceiling price for such drug (as described in paragraph (1)).”.

(b) Delaying Implementation of 340B Rebate Model Pilot Program.— For the period beginning on January 1, 2027, the date of enactment of this section, and ending on December 31, 2028, the Secretary of Health and Human Services may not implement the 340B Rebate Model Pilot Program described in the notice titled “Notice Regarding 340B Rebate Model Pilot Program” (91 Fed. Reg. 48883 (August 3, 2026)), or any substantially similar program. <all>

Text versions (1)
  • Introduced in House · Oct 9, 2026

Only one text version is on file, so there’s no earlier version to compare against yet.

Comments

Comments

Loading comments…